IRBEA 300mg price in UAE

Overview

Welcome to Dwaey, specifically on IRBEA 300mg Tablets page.
This medicine contains an important and useful components, as it consists of Irbesartan.
IRBEA 300mg is available in the market in concentration 300mg/Tablet and in the form of Tablets.

LABORATORIOS CINFA S.A is the producer of IRBEA 300mg and it is imported from SPAIN, The most popular alternatives of IRBEA 300mg are listed downward .

Mode Of Action

Irbesartan is an angiotensin II receptor antagonist. It blocks the vasoconstricting and aldosterone-secreting effects of angiotensin II by binding to AT1 receptors.

Indication

Diabetic nephropathy
Hypertension

Precaution

Child <6 yr. Unilateral or bilateral renal artery stenosis; vol or Na depletion; aortic or mitral valve stenosis, hypertrophic cardiomyopathy. Lactation: Potential harm to nursing infant; discontinue drug, or do not nurse

Side Effects

>10% Hyperkalemia (19%) 1-10% Dizziness (10%)
Upper respiratory tract infection (URTI) (9%)
Orthostatic hypotension (5%)
Fatigue (4%)
Diarrhea (3%)
Dyspepsia (2%)

Contra indication

Hypersensitivity; pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy category: 1st trimester, C; 2nd and 3rd trimesters, D

Interaction

May antagonise hypotensive effect and increase risk of nephrotoxicity w/ NSAIDs. May increase serum lithium levels and toxicity. Increased risk of hyperkalaemia w/ K-sparing diuretics (e.g. amiloride, triamterene, spironolactone), K supplements or K-containing salt substitutes. Potentially Fatal: May increase nephrotoxic, hyperkalaemic and hypotensive effect w/ aliskiren in patients w/ diabetes and renal impairment (GFR <60 mL/min).